Skip to content
ClinCalc Pro
Menu
First-generation oral cephalosporin

Cefadroxil

Brand names: Baxan (UK historical), Duricef

Cefadroxil is an oral first-generation cephalosporin antibiotic used for susceptible skin and soft-tissue, urinary tract and streptococcal throat infections.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is bactericidal, binding penicillin-binding proteins to inhibit cross-linking of bacterial cell-wall peptidoglycan, causing cell death.

Prescribing in practice

  • Avoid in patients with a history of immediate or severe hypersensitivity to penicillins or cephalosporins because of the risk of cross-reactivity.
  • Dose interval should be extended in renal impairment as it is renally cleared (consult the SPC).
  • Like other broad-spectrum agents, it can predispose to Clostridioides difficile and candidal superinfection.

Monitoring

Routine monitoring is not required, though renal function guides dosing in impairment; review for allergy and new diarrhoea.

Counselling the patient

  • Take the full course as prescribed even if symptoms improve quickly.
  • Seek urgent help for any rash, facial swelling or difficulty breathing.
  • Report severe or bloody diarrhoea promptly.

Evidence & guidelines

Cefadroxil is a well-established oral cephalosporin whose use is supported by long clinical experience and the SPC.

Reference: SmPC Duricef; NICE CKS Sore Throat; UKHSA UTI Guidelines 2024; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.